PPD, Inc. is a leading global contract research organization providing drug discovery and development services, post-approval expertise and compound partnering programs. The company' s clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. The company' s development services include preclinical drug discovery services, Phase I through Phase IV clinical development services and post-approval services, as well as bioanalytical, cGMP, global central laboratory and vaccines and biologics laboratory services.

Company was acquired by The Carlyle Group

Acquired Companies: InnoPharm Ltd, X-Chem, Inc., Magen BioSciences, BioDuro, Inc., Excel Pharma Studies